Zogenix to Present New Case Study Highlighting Successful Repositioning of Injectable Sumatriptan for Migraine With a Novel Needle-Free Delivery Technology

[at noodls] – Presentation at the 2nd Annual Drug Repositioning & Indications Discovery Conference to Demonstrate Increased Adoption of a Standard Therapy Used With DosePro(R) Technology SAN DIEGO, Oct. 23, 2012 (GLOBE … more

View todays social media effects on ZGNX

View the latest stocks trending across Twitter. Click to view dashboard